NEWARK, Calif., Sept. 3, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (STEM) today announced that interim six-month data from the first patient cohort in the Company's Phase I/II clinical trial of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback